Sp125
HCC: NEW PARADIGMS AND UNCERTAINTIES IN TREATMENT
Date
May 18, 2024
Presenter
Yale University School of Medicine
Tracks
Related Products
EXPLORING MECHANISMS UNDERLYING PATHOBIOLOGY AND DRUG CANDIDATES OF HEPATOCELLULAR CARCINOMA USING BIOINFORMATICS APPROACHES
BACKGROUND: The LI-RADS (Liver Reporting and Data Systems) was created to standardize reporting of CT/MR imaging for liver masses in cirrhosis patients at risk of hepatocellular carcinoma (HCC)…
THE ASSOCIATION BETWEEN MENTAL ILLNESS AND ALL-CAUSE MORTALITY IN PATIENTS WITH CIRRHOSIS: A VETERANS AFFAIRS RETROSPECTIVE COHORT STUDY
BACKGROUND: Alcoholic hepatitis (AH) is a life-threatening form of alcohol-associated liver disease (ALD), with no effective therapy…
